{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:46:19Z","timestamp":1791837979947,"version":"4.3.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010115","name":"R\u00e9gion Auvergne-Rh\u00f4ne-Alpes","doi-asserted-by":"publisher","award":["014712 01 40890"],"award-info":[{"award-number":["014712 01 40890"]}],"id":[{"id":"10.13039\/501100010115","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012964","name":"Enseignement Sup\u00e9rieur et de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004562","name":"Minist\u00e8re de l'Enseignement sup\u00e9rieur et de la Recherche","doi-asserted-by":"publisher","award":["50314TG"],"award-info":[{"award-number":["50314TG"]}],"id":[{"id":"10.13039\/501100004562","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biochi.2026.10.012","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:19:28Z","timestamp":1791587968000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Digestive lipases as therapeutic targets in obesity: From Orlistat to next-generation inhibitors"],"prefix":"10.1016","author":[{"given":"Sihem","family":"Snini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannet","family":"Kamoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emna","family":"Moujehed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Noiriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6637-668X","authenticated-orcid":false,"given":"Ahmed","family":"Aloulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8020-4294","authenticated-orcid":false,"given":"Abdelkarim","family":"Abousalham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2026.10.012_bib1","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","article-title":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults","volume":"390","author":"Abarca-G\u00f3mez","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.biochi.2026.10.012_bib2","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.apsb.2023.01.012","article-title":"Pathophysiology of obesity and its associated diseases","volume":"13","author":"Jin","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biochi.2026.10.012_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g2646","article-title":"Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials","volume":"348","author":"Dombrowski","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.biochi.2026.10.012_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/2042098613489721","article-title":"Safety of antiobesity drugs","volume":"4","author":"Cheung","year":"2013","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.biochi.2026.10.012_bib5","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1001\/jama.2016.7602","article-title":"Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis","volume":"315","author":"Khera","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.biochi.2026.10.012_bib6","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biochi.2026.10.012_bib7","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1038\/s41366-025-01859-6","article-title":"Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis","volume":"49","author":"Ismaiel","year":"2025","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.biochi.2026.10.012_bib8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4093\/dmj.2025.0242","article-title":"Exploring the side effects of GLP-1 receptor agonist: to ensure its optimal positioning","volume":"49","author":"Kim","year":"2025","journal-title":"Diabetes Metab. J"},{"key":"10.1016\/j.biochi.2026.10.012_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103363","article-title":"The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions","volume":"86","author":"Moiz","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.biochi.2026.10.012_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/20420188251406456","article-title":"GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications","volume":"16","author":"Ramirez-Mejia","year":"2025","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.biochi.2026.10.012_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/3527601910.ch10","article-title":"Physiology of gastrointestinal lipolysis and therapeutical use of lipases and digestive lipase inhibitors","author":"Lengsfeld","year":"2004","journal-title":"Lipases and Phospholipases in Drug Development"},{"key":"10.1016\/j.biochi.2026.10.012_bib12","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0300-9084(00)01179-2","article-title":"Digestive lipases: from three-dimensional structure to physiology","volume":"82","author":"Miled","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.biochi.2026.10.012_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF00493829","article-title":"Immunocytolocalization of human gastric lipase in chief cells of the fundic mucosa","volume":"91","author":"Moreau","year":"1989","journal-title":"Histochemistry"},{"key":"10.1016\/j.biochi.2026.10.012_bib14","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0016-5085(93)90908-U","article-title":"Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans","volume":"105","author":"Carriere","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biochi.2026.10.012_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/29.2.6166657","article-title":"Immunohistochemical localization of pancreatic exocrine enzymes in normal and neoplastic pancreatic acinar epithelium of rat","volume":"29","author":"Hansen","year":"1981","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.biochi.2026.10.012_bib16","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1021\/bi982601x","article-title":"Human pancreatic lipase: colipase dependence and interfacial binding of lid domain mutants","volume":"38","author":"Bezzine","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2026.10.012_bib17","doi-asserted-by":"crossref","first-page":"16995","DOI":"10.1074\/jbc.274.24.16995","article-title":"Crystal structure of human gastric lipase and model of lysosomal acid lipase, two lipolytic enzymes of medical interest","volume":"274","author":"Roussel","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biochi.2026.10.012_bib18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/343771a0","article-title":"Structure of human pancreatic lipase","volume":"343","author":"Winkler","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2026.10.012_bib19","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.bbalip.2006.06.009","article-title":"Exploring the specific features of interfacial enzymology based on lipase studies","volume":"1761","author":"Aloulou","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biochi.2026.10.012_bib20","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1074\/jbc.M109484200","article-title":"Crystal structure of the open form of dog gastric lipase in complex with a phosphonate inhibitor","volume":"277","author":"Roussel","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biochi.2026.10.012_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/359159a0","article-title":"Structure of the pancreatic lipase-procolipase complex","volume":"359","author":"van Tilbeurgh","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2026.10.012_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/bi961991p","article-title":"Pancreatic lipase structure-function relationships by domain exchange","volume":"36","author":"Carriere","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2026.10.012_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1389203003381487","article-title":"The C-terminal domain of pancreatic lipase: functional and structural analogies with c2 domains,","volume":"1","author":"Chahinian","year":"2000","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.biochi.2026.10.012_bib24","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1021\/bi0518803","article-title":"How gastric lipase, an interfacial enzyme with a ser-his-asp catalytic triad, acts optimally at acidic pH","volume":"45","author":"Chahinian","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2026.10.012_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1432-1033.1986.tb09583.x","article-title":"Human gastric lipase. The effect of amphiphiles,","volume":"156","author":"Gargouri","year":"1986","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.biochi.2026.10.012_bib26","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1053\/gast.2000.18140","article-title":"The specific activities of human digestive lipases measured from the in vivo and in vitro lipolysis of test meals,","volume":"119","author":"Carriere","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biochi.2026.10.012_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1021\/bi00595a001","article-title":"Inhibition of lipase adsorption at interfaces. Role of bile salt micelles and colipase","volume":"17","author":"Lairon","year":"1978","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2026.10.012_bib28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/pro.5560040107","article-title":"Crystallographic study of the structure of colipase and of the interaction with pancreatic lipase","volume":"4","author":"Egloff","year":"1995","journal-title":"Protein Sci."},{"key":"10.1016\/j.biochi.2026.10.012_bib29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0167-7799(96)10064-0","article-title":"\u2018Interfacial activation\u2019 of lipases: facts and artifacts","volume":"15","author":"Verger","year":"1997","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.biochi.2026.10.012_bib30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0304-4157(98)00016-1","article-title":"Structural basis for the substrate selectivity of pancreatic lipases and some related proteins","volume":"1376","author":"Carri\u00e8re","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biochi.2026.10.012_bib31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0968-0896(96)00251-9","article-title":"In vivo and in vitro studies on the stereoselective hydrolysis of tri- and diglycerides by gastric and pancreatic lipases","volume":"5","author":"Carriere","year":"1997","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biochi.2026.10.012_bib32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0005-2760(86)90234-1","article-title":"Importance of human gastric lipase for intestinal lipolysis: an in vitro study","volume":"879","author":"Gargouri","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biochi.2026.10.012_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1079\/PNS19960008","article-title":"Regulation of lumen fat digestion: enzymic aspects","volume":"55","author":"Verger","year":"1996","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.biochi.2026.10.012_bib34","doi-asserted-by":"crossref","first-page":"G16","DOI":"10.1152\/ajpgi.2001.281.1.G16","article-title":"Inhibition of gastrointestinal lipolysis by Orlistat during digestion of test meals in healthy volunteers","volume":"281","author":"Carriere","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biochi.2026.10.012_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2023.112785","article-title":"Pre-duodenal lipid digestion of emulsions: relevance, colloidal aspects and mechanistic insight","volume":"168","author":"Infantes-Garcia","year":"2023","journal-title":"Food Res. Int."},{"key":"10.1016\/j.biochi.2026.10.012_bib36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0005-2760(88)90260-3","article-title":"Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin","volume":"962","author":"Borgstrom","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biochi.2026.10.012_bib37","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.7164\/antibiotics.40.1081","article-title":"Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity","volume":"40","author":"Weibel","year":"1987","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.biochi.2026.10.012_bib38","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.7164\/antibiotics.40.1086","article-title":"Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. II. Chemistry and structure elucidation","volume":"40","author":"Hochuli","year":"1987","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.biochi.2026.10.012_bib39","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0021-9258(18)52203-1","article-title":"The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase","volume":"266","author":"Hadvary","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biochi.2026.10.012_bib40","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1128\/AEM.01765-14","article-title":"Operon for biosynthesis of lipstatin, the beta-lactone inhibitor of human pancreatic lipase","volume":"80","author":"Bai","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"issue":"Suppl 3","key":"10.1016\/j.biochi.2026.10.012_bib41","first-page":"S12","article-title":"Mode of action of orlistat","volume":"21","author":"Guerciolini","year":"1997","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.biochi.2026.10.012_bib42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.molcatb.2008.11.003","article-title":"Inhibition of human pancreatic lipase by tetrahydrolipstatin: further kinetic studies showing its reversibility","volume":"58","author":"Tiss","year":"2009","journal-title":"J. Mol. Catal. B Enzym."},{"key":"10.1016\/j.biochi.2026.10.012_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0009-3084(02)00051-8","article-title":"Transfer of orlistat through oil-water interfaces","volume":"119","author":"Tiss","year":"2002","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.biochi.2026.10.012_bib44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00002018-200831010-00005","article-title":"Orlistat-associated adverse effects and drug interactions: a critical review","volume":"31","author":"Filippatos","year":"2008","journal-title":"Drug Saf."},{"key":"10.1016\/j.biochi.2026.10.012_bib45","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1463-1326.2002.00237.x","article-title":"The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial","volume":"4","author":"Hanefeld","year":"2002","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.biochi.2026.10.012_bib46","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2337\/diacare.25.6.1033","article-title":"Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: a 1-year randomized controlled trial","volume":"25","author":"Kelley","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biochi.2026.10.012_bib47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1462-8902.2004.00359.x","article-title":"Effects of orlistat on obesity-related diseases - a six-month randomized trial","volume":"6","author":"Guy-Grand","year":"2004","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.biochi.2026.10.012_bib48","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.2337\/diacare.21.8.1288","article-title":"Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study","volume":"21","author":"Hollander","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biochi.2026.10.012_bib49","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1046\/j.1365-2036.2003.01530.x","article-title":"Impact of carbohydrate and fat intake on weight-reducing efficacy of orlistat","volume":"17","author":"Ullrich","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.biochi.2026.10.012_bib50","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/ajcn\/80.6.1461","article-title":"Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet: a systematic review of randomized clinical trials","volume":"80","author":"Hutton","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.biochi.2026.10.012_bib51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/oby.2000.8","article-title":"Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European orlistat obesity study group","volume":"8","author":"Rossner","year":"2000","journal-title":"Obes. Res."},{"key":"10.1016\/j.biochi.2026.10.012_bib52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","article-title":"Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European multicentre orlistat study group","volume":"352","author":"Sjostrom","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.biochi.2026.10.012_bib53","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000329409","article-title":"Multi-factorial approach associated with a new 'on\/off' Orlistat(R) use in a weight loss maintenance programme: 4 years follow-up","volume":"4","author":"Makoundou","year":"2011","journal-title":"Obes. Facts"},{"key":"10.1016\/j.biochi.2026.10.012_bib54","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12916-025-04200-0","article-title":"Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications","volume":"23","author":"Wu","year":"2025","journal-title":"BMC Med."},{"key":"10.1016\/j.biochi.2026.10.012_bib55","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/sj.ijo.0801128","article-title":"One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor","volume":"24","author":"Finer","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.biochi.2026.10.012_bib56","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/jama.2024.10816","article-title":"Medications for obesity: a review","volume":"332","author":"Gudzune","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.biochi.2026.10.012_bib57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/00912709922007543","article-title":"Long-term systemic exposure of orlistat, a lipase inhibitor, and its metabolites in obese patients","volume":"39","author":"Zhi","year":"1999","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.biochi.2026.10.012_bib58","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/cob.12075","article-title":"Orlistat-induced fulminant hepatic failure","volume":"4","author":"Sall","year":"2014","journal-title":"Clin Obes"},{"key":"10.1016\/j.biochi.2026.10.012_bib59","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.amjmed.2005.12.003","article-title":"Severe hepatic injury caused by orlistat","volume":"119","author":"Umemura","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.biochi.2026.10.012_bib60","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/j.1552-4604.1996.tb04230.x","article-title":"The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers","volume":"36","author":"Melia","year":"1996","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.biochi.2026.10.012_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109873","article-title":"Interpretable machine learning and molecular simulations identify natural pancreatic lipase inhibitors and hydrophobic hotspot residues","volume":"176","author":"Zhao","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biochi.2026.10.012_bib62","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jpba.2013.03.007","article-title":"Isolation and characterization of bioactive compounds from plant resources: the role of analysis in the ethnopharmacological approach","volume":"87","author":"Brusotti","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.biochi.2026.10.012_bib63","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1039\/C8FO02009D","article-title":"Identification of a new natural gastric lipase inhibitor from star anise","volume":"10","author":"Kamoun","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.biochi.2026.10.012_bib64","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/3527601910.ch9","article-title":"Digestive lipases inhibition: an In vitro study","author":"Tiss","year":"2004","journal-title":"Lipases and Phospholipases in Drug Development"},{"key":"10.1016\/j.biochi.2026.10.012_bib65","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2125.2008.03311.x","article-title":"Reduction of dietary fat absorption by the novel gastrointestinal lipase inhibitor cetilistat in healthy volunteers","volume":"67","author":"Bryson","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.biochi.2026.10.012_bib66","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/sj.ijo.0803446","article-title":"Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients","volume":"31","author":"Kopelman","year":"2007","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.biochi.2026.10.012_bib67","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.phymed.2011.01.002","article-title":"Antiobesity and lipid lowering effects of glycyrrhiza chalcones: experimental and computational studies","volume":"18","author":"Birari","year":"2011","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biochi.2026.10.012_bib68","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1021\/acs.jnatprod.0c01387","article-title":"Natural isoflavones and semisynthetic derivatives as pancreatic lipase inhibitors","volume":"84","author":"Cardullo","year":"2021","journal-title":"J. Nat. Prod."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030090842600249X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030090842600249X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:03:11Z","timestamp":1791835391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030090842600249X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":68,"alternative-id":["S030090842600249X"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2026.10.012","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Digestive lipases as therapeutic targets in obesity: From Orlistat to next-generation inhibitors","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2026.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}